Published in Vaccine Weekly, August 17th, 2005
A key monoclonal antibody clinically shown to play an important role in fighting juvenile diabetes, anti-CD3 targets an antigen expressed on T lymphocytes, the cells of the immune system that are responsible for the destruction of islet cells of the pancreas and could slow the progression of the disease in children and adolescents.
A phase I...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly